BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Pharm Country

  Axsome Therapeutics Announces Closing of $9.5M Registered Direct Offering

  The gross proceeds of the offering were approximately $9.5 million.

  December 6, 2017

   · 

  4 min read
• Pharm Country

  O’Brien Medical Launches New Instrument for Diabetes Market

  Now clinicians can implement a standardized approach for diagnosing diabetic peripheral neuropathy utilizing the three most popular frequencies in medicine.

  December 6, 2017

   · 

  1 min read
• Microfluidic Mixing With MXR Now Available for Products From microfluidic ChipShop

  microfluidic ChipShop GmbH today announced that its products are now available with MXR, the world’s fastest, most adaptable microfluidic mixing chip.

  December 6, 2017

   · 

  2 min read
• Business

  COMPASS Pathways Partners With Worldwide Clinical Trials to Conduct World’s First Large-scale Clinical Trials in Psilocybin Therapy for Treatment-resistant Depression

  December 6, 2017

   · 

  5 min read
• Business

  TetraGenetics and ModiQuest Collaborating for the Discovery of Therapeutic Antibodies Against KCa3.1

  The alliance is focused on the discovery of novel monoclonal antibodies against KCa3.1, a well-validated target for fibrosis, vasculoproliferative disorders and immunomodulation to treat autoimmune and inflammatory disorders.

  December 6, 2017

   · 

  3 min read
• Drug Development

  Arch Biopartners Announces Completion of GMP Manufacturing of AB569 and Start Date of Phase I Trial

  AB569 is the Company’s inhalation drug candidate for treating antibiotic-resistant bacterial infections in the lungs of cystic fibrosis.

  December 6, 2017

   · 

  3 min read
• SYGNIS AG Launches TruePrime Apoptotic Cell Free DNA Amplification Kit for the Liquid Biopsy Market

  The kit enables accurate DNA amplification using cfDNA obtained from plasma, serum, urine, CSF, or many other bodily fluids.

  December 6, 2017

   · 

  3 min read
• Policy

  FDA Accepts NDA for Buprenorphine Sublingual Spray From INSYS Therapeutics

  Novel formulation of partial opioid offers potential benefits compared to current alternatives.

  December 6, 2017

   · 

  3 min read
• Business

  Clinigen Plc Directorate Change

  Clinigen announces that Chris Rigg has resigned with immediate effect as a director to seek a CEO role elsewhere.

  December 6, 2017

   · 

  1 min read
• Drug Development

  Minerva Neurosciences Announces Enrollment of First Patient in Phase IIb Trial of Seltorexant (MIN-202) in Patients With Insomnia Disorder

  The primary objective of this trial is to assess the dose-response of three doses of seltorexant compared to placebo on sleep onset as measured by the latency to persistent sleep using polysomnography.

  December 6, 2017

   · 

  4 min read